Medtronic (BSP:MDTC34) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


BSP:MDTC34 Medtronic PLC BSP:MDTC34
67 GF Score
Price R$209.95
GF Value R$260.36
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Medtronic's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BSP:MDTC34 vs SYK, BSX, EW: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Medtronic's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medtronic Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Medtronic's Margin of Safety % (DCF Earnings Based) falls into.


BSP:MDTC34
67GF Score
Medtronic PLC BSP:MDTC34
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$209.95 is trading 19.4% below its estimated GF Value™ of R$260.36. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: R$260.36 vs. price of R$209.95 (19.4% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
67GF Score

Get the complete analysis for BSP:MDTC34

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$209.95
Price
R$260.36
GF Value